|
⚲
|
| Keyboard |
| Rapport Therapeutics Inc | |
|---|---|
| Ticker | RAPP |
| CIK # | 0002012593 |
| CUSIP | 75383L102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1325 Boylston Street Suite 401, Boston, MA 02215 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0002012593] | 10-K | |
| [0002012593] | 10-Q | |
| [0002012593] | 3 | |
| [0002012593] | 4 | |
| [0002012593] | 8-K | |
| [0002012593] | SC 13D | |
| [0002012593] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Gault Cheryl
Common Stock
|
2026-03-30 | Sell | 2,839 | $28.55 | 81,053 |
|
Gault Cheryl
Common Stock
|
2026-03-30 | Sell | 7,161 | $28.04 | 200,794 |
|
Yeleswaram Krishnaswamy
Common Stock
|
2026-03-25 | Sell | 10,115 | $29.99 | 303,349 |
|
Gault Cheryl
Common Stock
|
2026-03-05 | Sell | 2,014 | $28.93 | 58,265 |
|
Bredt David
Stock Options (Right to Buy) · derivative
|
2026-02-19 | Option exercise | 6,000 | $0.00 | |
|
Bredt David
Common Stock
|
2026-02-19 | Option exercise | 6,000 | $1.80 | 10,800 |
|
Ceesay Abraham
Common Stock
|
2026-02-18 | Sell | 2,281 | $29.80 | 67,974 |
|
Ceesay Abraham
Common Stock
|
2026-02-18 | Sell | 3,552 | $29.05 | 103,186 |
|
Ceesay Abraham
Common Stock
|
2026-02-18 | Sell | 2,100 | $29.80 | 62,580 |
|
Ceesay Abraham
Common Stock
|
2026-02-18 | Sell | 2,983 | $29.04 | 86,626 |
|
Bredt David
Common Stock
|
2026-02-17 | Sell | 5,400 | $28.95 | 156,330 |
|
Bredt David
Common Stock
|
2026-02-17 | Sell | 2,200 | $29.59 | 65,098 |
|
Bredt David
Common Stock
|
2026-02-17 | Sell | 900 | $28.02 | 25,218 |
|
Gault Cheryl
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 132,000 | $0.00 | |
|
Sevigny Jeffrey
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 130,000 | $0.00 | |
|
Ceesay Abraham
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 428,000 | $0.00 | |
|
Ignelzi Troy A
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 148,000 | $0.00 | |
|
Yeleswaram Krishnaswamy
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 120,000 | $0.00 | |
|
Bredt David
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 103,000 | $0.00 | |
|
Ceesay Abraham
Common Stock
|
2026-01-20 | Sell | 5,833 | $26.12 | 152,358 |
| showing 20 of 125 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 147 | 51,072,773 |
| 2025-12-31 | 145 | 49,665,517 |
| 2025-09-30 | 124 | 47,918,506 |
| 2025-06-30 | 82 | 36,377,363 |
| 2025-03-31 | 78 | 35,507,497 |
| 2024-12-31 | 71 | 33,821,163 |
| 2024-09-30 | 56 | 25,679,511 |
| 2024-06-30 | 36 | 22,665,656 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Swedbank AB | [2026-06-30] | DFND | 117,400 | 117,400 |
| Ellsworth Advisors LLC | [2026-06-30] | SOLE | 0 | 24,539 |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 19,189 | 19,189 |
| PSP Research LLC | [2026-06-30] | SOLE | 0 | 14,000 |
| Gamma Investing LLC | [2026-06-30] | DFND | 408 | 408 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 163 | 163 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 41 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 27 | 27 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 3 | 3 | Prev | Page 1 | Next |